The Biden administration on Friday put in place stringent curbs aimed at thwarting rogue insurance brokers from switching consumers’ Affordable Care Act plans without their consent.
Antios reportedly shut down; Clene’s long-term ALS data; Keytruda, Lenvima’s lung cancer failures
Plus, Valneva signs US contract for Ixiaro, and Pierre Fabre inks a cancer deal with Vernalis. Hepatitis B startup Antios Therapeutics shuts down — report